Health
Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction - STAT

What the report says
As telehealth promotes GLP-1s for addiction, experts worry about fragmented care, and exposing patients to unknown risks.
Loading debate for this article…
Other publishers covering this story
No additional verified coverage is currently clustered with this report.

Lango Seeks Japanese Investment in Agriculture, Industry and Social ServicesNile Post
Medicine shortages undermining village health teamsThe Observer
Depression: Walking Through the Three Corners of Life Toward HealingNile Post
Ebola: Uganda Reinstates Traveller Locator FormsNile Post
Atwine Warns Border Officers Over Ebola Screening Lapses at MpondweNile Post